Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB1 | Q9H4B7 | 3/20 | 0.70 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.70 |
| ▸ | TUBB | P07437 | 1/20 | 0.70 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.70 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.70 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.70 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.70 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.70 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.70 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.70 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.70 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.70 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.70 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.70 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.65 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.65 |
| ▸ | ABL1 | P00519 | 1/20 | 0.65 |
| ▸ | BCR | P11274 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2927389 | 1.00 | TUBB1 (0.70) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL3645732 | 0.93 | TUBB1 (0.70) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL2718303 | 0.93 | TUBB1 (0.70) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL2718300 | 0.93 | TUBB1 (0.70) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL3645729 | 0.93 | TUBB1 (0.70) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL6844172 | 0.90 | TUBB1 (0.76) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL14000544 | 0.90 | TUBB1 (0.76) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL16372856 | 0.88 | ABL1 (0.80) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL17843663 | 0.88 | ABL1 (0.80) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL21428998 | 0.85 | ERN1 (0.57) | TUBB1TUBB4ATUBBTUBA3CTUBA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012129499-A1 | TREATMENT OF INFLAMMATORY AND INFECTIOUS SKIN DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-09-27 | — | — | WO | claimed |
| CN-101225027-A | Compound (E)-4-hydroxy-3,5-dimethoxystilbene and preparation thereof | UNIV NORTHWEST NORMAL (CN) | 2008-07-23 | — | — | CN | claimed |
| US-12595220-B2 | Cocrystals of pterostilbene and compositions comprising them | CENTER FOR INTELLIGENT RESEARCH IN CRYSTAL ENGINEERING, S.L. (ES) | 2026-04-07 | — | — | US | disclosed |
| EP-4077258-B1 | COCRYSTALS OF PTEROSTILBENE AND COMPOSITIONS COMPRISING THEM | CENTER FOR INTELLIGENT RES IN CRYSTAL ENGINEERING S L (ES) | 2026-03-25 | — | — | EP | disclosed |
| US-12466784-B2 | Analogs of pterostilbene amino acid bearing carbonates for treating a non-alcoholic fatty liver disease and nonalcoholic steatohepatitis | APICAL MOLECULAR BIOTECH CO., LTD. (TW) | 2025-11-11 | — | — | US | disclosed |
| EP-4136063-B1 | NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS | APICAL MOLECULAR BIOTECH CO LTD (TW) | 2025-10-22 | — | — | EP | disclosed |
| EP-4541351-A1 | COMPOUNDS AND COMBINATION AS STIMULATORS OF COLLAGEN SYNTHESIS | Center for Intelligent Research in Crystal Engineering, S.L. (ES) | 2025-04-23 | — | — | EP | disclosed |
| CN-119193523-A | Resveratrol methylase, expression vector, expression cassette and recombinant strain | 中国科学院上海有机化学研究所 | 2024-12-27 | — | — | CN | disclosed |
| CN-114929659-B | Co-crystals of pterostilbene and compositions containing same | 晶体工程智能研究中心公司 | 2024-05-28 | — | — | CN | disclosed |
| US-11957727-B2 | Prevention of neuroinflammation associated memory loss using nutraceutical compositions | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC (US) | 2024-04-16 | — | — | US | disclosed |
| US-11951146-B2 | Stimulation of NK cell activity by using a combination of broccoli, Nigella Sativa, Green Tea, and pterostilbene alone and together with metformin | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (US) | 2024-04-09 | — | — | US | disclosed |
| EP-2231133-A2 | METHOD AND COMPOSITIONS FOR ADMINISTERING RESVERATROL AND PTEROSTILBENE | Rubin, David (US) | 2010-09-29 | — | — | EP | disclosed |
| EP-2231847-A1 | METHOD AND COMPOSITIONS FOR PRESERVING WINE | Rubin, David (US) | 2010-09-29 | — | — | EP | disclosed |
| CN-101820869-A | Method for reducing oxidative stress and improving working memory by administering pterostilbene | US AGRICULTURE | 2010-09-01 | — | — | CN | disclosed |
| WO-2010046926-A2 | NOVEL STILBENE ANALOGS | APTUIT LAURUS PVT LTD (IN) | 2010-04-29 | — | — | WO | disclosed |
| WO-2009089338-A2 | METHOD AND COMPOSITIONS FOR ADMINISTERING RESVERATROL AND PTEROSTILBENE | RUBIN DAVID (US) | 2009-07-16 | — | — | WO | disclosed |
| WO-2009089334-A1 | METHOD AND COMPOSITIONS FOR PRESERVING WINE | RUBIN DAVID (US) | 2009-07-16 | — | — | WO | disclosed |
| CN-101225027-A | Compound (E)-4-hydroxy-3,5-dimethoxystilbene and preparation thereof | UNIV NORTHWEST NORMAL (CN) | 2008-07-23 | — | — | CN | disclosed |
| CN-101225027-A | Compound (E)-4-hydroxy-3,5-dimethoxystilbene and preparation thereof | UNIV NORTHWEST NORMAL (CN) | 2008-07-23 | — | — | CN | disclosed |
| CN-101225027-A | Compound (E)-4-hydroxy-3,5-dimethoxystilbene and preparation thereof | UNIV NORTHWEST NORMAL (CN) | 2008-07-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595220-B2 | Cocrystals of pterostilbene and compositions comprising them | SHBG, PSEN1, SREBF1 | TUBB1 1066/4885TUBB4A 2352/4885TUBB 1356/4885 |
| US-12466784-B2 | Analogs of pterostilbene amino acid bearing carbonates for treating a non-alcoholic fatty liver disease and nonalcoholic steatohepatitis | FABP1, GLS2, SLC1A5 | TUBB1 4030/4885TUBB4A 4391/4885TUBB 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.